# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028168
Filing Date
2022-11-03
Accepted
2022-11-03 16:02:33
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20220930.htm iXBRL | 10-Q | 1484601
2 | EX-5.1 | sgmo-2022110322xex51opin.htm | EX-5.1 | 5477
3 | EX-10.1 | sgmo-20220930xex101_employ.htm | EX-10.1 | 33942
4 | EX-31.1 | sgmo-20220930xex311.htm | EX-31.1 | 10124
5 | EX-31.2 | sgmo-20220930xex312.htm | EX-31.2 | 10239
6 | EX-32.1 | sgmo-20220930xex321.htm | EX-32.1 | 7206
12 | GRAPHIC | sgmo-20220930_g1.jpg | GRAPHIC | 515814
13 | GRAPHIC | sgmo-20220930_g2.jpg | GRAPHIC | 535020
14 | GRAPHIC | sgmo-20220930_g3.jpg | GRAPHIC | 613355
15 | GRAPHIC | sgmo-20220930_g4.jpg | GRAPHIC | 526354
16 | GRAPHIC | sgmo-2022110322xex51opin001.jpg | GRAPHIC | 254758
17 | GRAPHIC | sgmo-2022110322xex51opin002.jpg | GRAPHIC | 73740
| Complete submission text file | 0001628280-22-028168.txt |  | 11997554

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20220930.xsd | EX-101.SCH | 42423
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20220930_cal.xml | EX-101.CAL | 67752
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20220930_def.xml | EX-101.DEF | 224914
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20220930_lab.xml | EX-101.LAB | 455192
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20220930_pre.xml | EX-101.PRE | 321977
55 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20220930_htm.xml | XML | 1204233

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 221357828
SIC: 2836 Biological Products, (No Diagnostic Substances)